Levels of both membrane-bound DPP-4 protein and plasma DPP-4 enzymatic activity are altered in several pathophysiological states, including cancer, inflammation, infections, immune disorders, type 2 diabetes, and kidney disease [28,31]. This evidence concerns the gene DPP4 and kidney disorder.